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cluding minute reports, workshop, letters (5), assessment/
opinion (2) from the CPMP and 2 documents were pro-
duced by the CVMP. CONCLUSIONS: The recommen-
dations from the EMEA are vague in most cases, too ge-
neric, inconsistent between each other and reveal in some
cases a lack of knowledge of the field. These recommen-
dations are not up-dated and do not exist in relevant dis-
eases (HIV/AIDS, HBP). Nevertheless, recommendations
do exist showing a real interest in HRQL and recognition
of HRQL as a valuable endpoint (mainly secondary).
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OBJECTIVES: This paper reviews current approaches to
defining clinically meaningful change in health-related
quality of life (HRQOL). METHODS: Definitions of
clinically meaningful change are discussed. Psychometric
properties of HRQOL instruments necessary for identify-
ing clinically meaningful change are identified. Two broad
methods for identifying clinically meaningful change are
contrasted: anchor-based methods and distribution-based
methods. Anchor-based methods include forced-choice
paradigms, global change ratings, receiver operating char-
acteristic techniques, goal attainment scaling and exter-
nal event methods. Distribution-based methods include
individual effect size, the Guyatt responsiveness index,
the Jacobson-Traux reliable-change index (and subsequent
variations), standard error of measurement, and hierar-
chical linear modeling. Strategies for validating clinically
meaningful change measures are discussed. RESULTS:
Anchor-based and distribution-based methods have both
advantages and limitations, and neither appears superior
to the other. Anchor-based methods provide a source for
external validation, but are dependent on the specific an-
chors being used. Distribution-based methods provide a
statistical basis for decision-making, but may vary on the
basis of sample characteristics. CONCLUSIONS: The use
of multiple methods to define clinically meaningful change
is strongly recommended. Factors to consider in defining
clinically meaningful change include the severity of the
baseline value, the direction of change, and the impor-
tance of the change to the individual.
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OBJECTIVE: To examine the cross-cultural differences
of health-related quality of life among people with vari-
ous health conditions across four countries. METHODS:
Analyses were based on 12-page questionnaires mailed to
adults in 2000. A total of 38,677 responses were received
from France, Germany, Great Britain, and the US Results
were subsequently weighted and projected to the national
populations of these four countries. Weighting was based
on gender, age, and region for the European countries
and gender, age, race, and region for the US Participants
reported whether they were diagnosed with the follow-
ing: arthritis, asthma, depression, diabetes, GERD, high
blood pressure, high cholesterol, migraines, nasal aller-
gies, or osteoporosis. Physical and mental health status
were defined by summary measures of the SF-12 scale.
RESULTS: The French reported lower mental health sta-
tus but better physical health status than people in Ger-
many, Great Britain, and the US, regardless of diagnosed
health conditions. The opposite was found among arthri-
tis, asthma, and GERD sufferers in Germany, who re-
ported the best mental health status but the lowest physi-
cal health. Respondents from Great Britain and the US
generally reported SF-12 scores that fell between those of
France and Germany, with three notable exceptions.
Among people diagnosed with depression, those in the
US reported better mental health status. Among people
diagnosed with high blood pressure or high cholesterol,
those in Great Britain reported the lowest physical health
status. CONCLUSION: Self-reported quality of life var-
ied by country regardless of condition. Researchers
should consider cross-cultural variations in self-reported
quality of life measures when conducting multinational
trials. Collapsing data could obscure effects.
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Despite widespread use of the SF-36, its use in cost-utility
analyses has been precluded by its inability to measure
patient preferences. To overcome this obstacle, various
investigators have derived equations to estimate prefer-
ence scores from the SF-36. OBJECTIVE: To compare
two methods of estimating preference values from SF-36
scores. METHODS: A convenience sample of patients
completed the SF-36 and EuroQol during their initial
visit to a specialty headache center. Preference scores
were estimated from the SF-36 using two equations, one
developed by Fryback and the other by Brazier. The per-
formance of each equation was assessed by calculating
the correlation coefficient between the estimates and ac-
tual preference scores from the EuroQol. Mean prefer-
ence scores from each method were compared using one-
way repeated measures ANOVA. RESULTS: Forty-seven
